<DOC>
	<DOCNO>NCT01607580</DOCNO>
	<brief_summary>Hematopoietic stem cell transplantation ( HSCT ) one best , sometimes , option treatment leukemia . However , GVHD rate still high haploidentical HSCT . It find previous study CD4/CD8 &gt; =1.16、CD56bright NK &gt; 1.9×106/kg graft associate high risk develop acute Graft-versus-host Disease ( GVHD ) . The study hypothesis : Risk stratification-directed low-dose glucocorticoid prophylaxis acute GVHD unmanipulated haploidentical blood marrow transplantation reduce incidence acute GVHD</brief_summary>
	<brief_title>Efficacy Study Low-dose Glucocorticoid Prophylaxis Acute Graft-versus-host Disease ( GVHD )</brief_title>
	<detailed_description>patient undergone haploidentical HSCT follow day 5 post transplant randomize treat group ( low-dose glucocorticoid ) control group ( intervention ) .</detailed_description>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<criteria>severe diarrhea serious infection serious diarrhea active , uncontrolled infection</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>